TrialDiabetes, obesity & metabolism2018

High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial.

You-Cheol Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.